Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-04-09

Clinical Trial Update: Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients [NA]

View source ↗

Summary

Clinical trial update examining whether zinc supplementation alters serum homocysteine levels in patients with end-stage renal disease undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinc supplementation (zinc)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: End Stage Renal Failure | NA | Status: COMPLETED